HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Study scrutinizes role of PSA in predicting prostate cancer risk
-
- Constant immune system activity could cause fatigue in breast cancer survivors
- Oral iron chelators show promise compared with IV deferoxamine
- Assessment model gauges lung cancer risk based on medical history and genetics
- Body mass index does not adversely affect survival from endometrial cancer
- Elderly and minority patients at risk for mismanaged cancer-related pain
- FDA advisory committee gives green light to Gardasil, a new HPV vaccine
- Physicians consider probiotics for management of antibiotic-associated diarrhea Marianne Billeter, PharmD, BCPS
- Sunitinib and sorafenib represent new treatment options for renal cell cancer Lisa K. Lohr, PharmD, BCPS, BCOP
-